Login / Signup

Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine.

Katarzyna J JerzakMarissa LaureanoRadwa ElsharawiPeter KavsakKelvin Kw ChanSukhbinder K Dhesy-ThindKevin Zbuk
Published in: Hypoxia (Auckland, N.Z.) (2017)
Patients with mCRC had higher venous pCO2 levels than those with local disease. Although causation cannot be established, we hypothesize that pCO2 elevation may stem from a perturbed metabolism in mCRC.
Keyphrases
  • mass spectrometry
  • cancer therapy
  • drug delivery